Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Non Operating Investment Income (2016 - 2022)

Historic Non Operating Investment Income for Marimed (MRMD) over the last 7 years, with Q1 2022 value amounting to $48000.0.

  • Marimed's Non Operating Investment Income rose 20666.67% to $48000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was -$1.0 million, marking a year-over-year decrease of 44663.23%. This contributed to the annual value of -$1.1 million for FY2021, which is 21649.68% down from last year.
  • According to the latest figures from Q1 2022, Marimed's Non Operating Investment Income is $48000.0, which was up 20666.67% from -$169203.0 recorded in Q4 2021.
  • Marimed's Non Operating Investment Income's 5-year high stood at $354534.0 during Q4 2020, with a 5-year trough of -$687002.0 in Q1 2020.
  • Moreover, its 3-year median value for Non Operating Investment Income was -$169203.0 (2021), whereas its average is -$156451.8.
  • As far as peak fluctuations go, Marimed's Non Operating Investment Income tumbled by 34018.79% in 2021, and later surged by 20666.67% in 2022.
  • Over the past 3 years, Marimed's Non Operating Investment Income (Quarter) stood at $354534.0 in 2020, then plummeted by 147.73% to -$169203.0 in 2021, then soared by 128.37% to $48000.0 in 2022.
  • Its last three reported values are $48000.0 in Q1 2022, -$169203.0 for Q4 2021, and -$522106.0 during Q3 2021.